HLA PRE-TRANSPLANT WORKUP SENSITIZED RECIPIENT PANEL 5 Test
Test cost: AED 4000.0
Symptoms, Diagnosis, and Referring Details:
Test Name: HLA PRE-TRANSPLANT WORKUP SENSITIZED RECIPIENT PANEL 5 Test
Components: Donor: HLA DNA Typing 10 antigens, Low resolution, Luminex
Price: 4000.0 AED
Sample Condition: DONOR: 4 mL (2 mL min.) whole blood in 1 Lavender top (EDTA) tube AND 4 mL (2 mL min.) whole blood in 1 Green Top (Sodium Heparin) tube. Ship at 18-22°C. DO NOT REFRIGERATE OR FREEZE. Doctor’s prescription on the letterhead with 1 photograph each of recipient and donor duly stamped AND Consent form for HLA Typing for Solid organ transplant (Form 33) is mandatory.
Report Delivery: 10-12 days
Method: Reverse SSOP – Luminex, Luminex X-Map technology, Flow cytometry
Test Type: Transplantation
Doctor: Nephrologist
Test Department:
Pre Test Information: Doctor’s prescription on the letterhead with 1 photograph each of recipient and donor duly stamped AND Consent form for HLA Typing for Solid organ transplant (Form 33) is mandatory.
Test Details:
The Sensitized Recipient Panel 5 (SRP5) test is a pre-transplant workup test that is used to determine the level of sensitization in a potential organ transplant recipient. Sensitization refers to the presence of antibodies in the recipient’s blood that may react with the donor organ and lead to organ rejection.
The SRP5 test specifically measures the presence of antibodies against five different human leukocyte antigens (HLAs) in the recipient’s blood. HLAs are proteins found on the surface of cells that are responsible for immune system recognition. Matching HLAs between the donor and recipient is important for successful organ transplantation.
The five HLAs tested in the SRP5 test are typically chosen based on the frequency of their occurrence in the general population. The test involves mixing the recipient’s blood with a panel of cells that express these specific HLAs. If the recipient’s blood contains antibodies against any of these HLAs, a reaction will occur, indicating sensitization.
The results of the SRP5 test are used to assess the level of sensitization in the recipient. This information is crucial for determining the compatibility between the potential donor and recipient. If the recipient is highly sensitized, finding a compatible donor may be more challenging, as the donor must have HLAs that do not match the recipient’s antibodies.
Overall, the SRP5 test is an important tool in the pre-transplant workup process, as it helps to identify potential barriers to successful organ transplantation and guides the selection of an appropriate donor for the sensitized recipient.
Test Name | HLA PRE-TRANSPLANT WORKUP SENSITIZED RECIPIENT PANEL 5 Test |
---|---|
Components | Donor: *HLA DNA Typing 10 antigens, Low resolution, Luminex |
Price | 4000.0 AED |
Sample Condition | DONOR: 4 mL (2 mL min.) whole blood in 1 Lavender top (EDTA) tubeAND4 mL (2 mL min.) whole blood in 1 Green Top (Sodium Heparin) tube. Ship at 18\u0192??22?\u00f8C. DO NOT REFRIGERATE OR FREEZE.Doctor’s prescription on the letter head with 1 photograph each of recipient and donor duly stamped AND Consent form for HLA Typing for Solid organ transplant (Form 33) is mandatory. |
Report Delivery | 10-12 days |
Method | Reverse SSOP – Luminex, Luminex X-Map technology, Flow cytometry |
Test type | Transplantation |
Doctor | Nephrologist |
Test Department: | |
Pre Test Information | Doctor’s prescription on the letter head with 1 photograph each of recipient and donor duly stamped AND Consent form for HLA Typing for Solid organ transplant (Form 33) is mandatory. |
Test Details |
The Sensitized Recipient Panel 5 (SRP5) test is a pre-transplant workup test that is used to determine the level of sensitization in a potential organ transplant recipient. Sensitization refers to the presence of antibodies in the recipient’s blood that may react with the donor organ and lead to organ rejection. The SRP5 test specifically measures the presence of antibodies against five different human leukocyte antigens (HLAs) in the recipient’s blood. HLAs are proteins found on the surface of cells that are responsible for immune system recognition. Matching HLAs between the donor and recipient is important for successful organ transplantation. The five HLAs tested in the SRP5 test are typically chosen based on the frequency of their occurrence in the general population. The test involves mixing the recipient’s blood with a panel of cells that express these specific HLAs. If the recipient’s blood contains antibodies against any of these HLAs, a reaction will occur, indicating sensitization. The results of the SRP5 test are used to assess the level of sensitization in the recipient. This information is crucial for determining the compatibility between the potential donor and recipient. If the recipient is highly sensitized, finding a compatible donor may be more challenging, as the donor must have HLAs that do not match the recipient’s antibodies. Overall, the SRP5 test is an important tool in the pre-transplant workup process, as it helps to identify potential barriers to successful organ transplantation and guides the selection of an appropriate donor for the sensitized recipient. |